Report #2895850

Received May 8, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 7 yrs
State: AR
Recovered: Unknown
Vaccinated: Apr 27, 2026
Onset: Apr 27, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
DTAPHEPBIP	DTAP + HEPB + IPV (PEDIARIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	72m4d	—

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

7 year old patient was given a dose of Pediarix/Drug use in unapproved age group; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 7-year-old female patient who received DTPa-HBV-IPV (Pediarix) (batch number 72m4d, expiry date 15-OCT-2027) for prophylaxis. On 27-APR-2026, the patient received Pediarix. On 27-APR-2026, an unknown time after receiving Pediarix, the patient experienced inappropriate age at vaccine administration (Verbatim: 7 year old patient was given a dose of Pediarix/Drug use in unapproved age group). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date:28-APR-2026 The patient was outside the recommended age for the vaccine.